- ‘A billion dollar green rush’
Forbes
MARIJUANA
MANIA
Four ASX marijuana plays set for imminent blast higher...
Potential ‘high-bagger’ 1,233% gains for the taking...
But only if you act before a critical announcement, due to break ANY DAY NOW.
Money morning, just announced,
- MXC might get a good run of this publication. GLA
- MGC Pharmaceuticals [ASX:MXC] sells a range of cannabinoid derived anti-ageing skincare products in California, Canada and the European Union. An early punt on MGC could have helped you to a ‘high-bagger’ 1,233% gain in only 26 months.
Source: Yahoo Finance
Mind-blowing gains, yes?
Remember though, the above stocks are fresh examples inside a —
ahem — ‘green’ healthcare sub-sector.
Which means they’re a lot riskier than your everyday blue-chip healthcare stocks like CSL, Resmed or Cochlear.
And you should only ever use money on higher-risk small-cap stocks that won’t ‘break the bank’.
But where there’s higher risk, you’ve also got a potential shot at creating immense fortunes.
Take another look at the last Aussie marijuana stock I showed you, MGC Pharmaceuticals. Since 2015, shares are up 1,233%.
A small $500 punt turned into $6,165 in just 26 months. Enough to walk out the front doors of Harvey Norman with a brand-spanking-new, 75-inch Sony Bravia HD TV under your arm.
If you’d had a little more money to risk — say, $5,000 — you’d have $61,650 sitting in your brokerage account right now. The kind of money that lets you deck out a whole private cinema room in your home…or even put a deposit down on a new house!
Again, exciting as those gains sound…I believe it’s nothing more than a dress rehearsal for what comes
next.
See, a crucial commercial marijuana licence announcement, which the Courier Mail says is ‘likely to be approved within weeks’ has the power to make gains already racked up by Australia’s early ‘pot plays’ like MGC Pharmaceuticals, Botanix and Medlab look tiny.
Few mainstream analysts understand the magnitude of this announcement…
Fewer still know what it means for the fortunes of four specific pot stocks at the centre of Australia’s fledgling marijuana industry.
In short, it could see the four pot plays I’ll unmask grab a big slice of an international medicinal marijuana market that Bank of America Merrill Lynch estimates could be worth as much as $35 billion in the next three years.
That’s why you need to look at this opportunity now. By the end of this month, your chance to lay claim to the biggest stock profits could be gone.
Today, these Aussie marijuana companies are tiny. The largest has a market cap of just $32 million. While that sounds big, in market terms it’s tiny.
But picture this…
Just 1% of that $35 billion marijuana market ($350,000,000!) would instantly re-rate this firm’s market value — and its shares — TENFOLD.
Yet, that’s only the
beginning of the gains you could eventually rack up from a well-timed marijuana investment.
Motley Fool reports legal marijuana could soon rival the
‘$200 billion alcohol industry’.
